دورية أكاديمية

721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study

التفاصيل البيبلوغرافية
العنوان: 721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study
المؤلفون: Basso, U., Paolieri, F., Porta, C.G., De Giorgi, U., Bracarda, S., Antonuzzo, L., Atzori, F., Cartenì, G., Procopio, G., Fratino, L., D'Arcangelo, M., Fornarini, G., Zucali, P.A., Cusmai, A., Santoni, M., Baldessari, C., Naglieri, E., Panni, S., Zagonel, V., Tortora, G.
المصدر: Annals of Oncology ; volume 31, page S566 ; ISSN 0923-7534
بيانات النشر: Elsevier BV
سنة النشر: 2020
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Oncology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.annonc.2020.08.793
الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.793Test
https://api.elsevier.com/content/article/PII:S0923753420407896?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753420407896?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/
رقم الانضمام: edsbas.C047D244
قاعدة البيانات: BASE